Seo Jung-jin

Seo Jung-jin

Seo Jung-jin (#465)

  • $ 8 B
  • Biotech
  • South Korea
  • M
  • 68 Years

About Me

Seo Jung-jin is cofounder of Celltrion, a biopharmaceutical firm that makes drugs to treat cancer, influenza and rheumatoid arthritis, among others. With the success of biosimilars in South Korea, his Celltrion has become a favorite among investors. In 2023, Seo returned as chairman of his Celltrion group, two years after stepping down from the role, and pledged to make major acquisitions. Seo's eldest son Jin-seok is cochairman of Celltrion Inc. Seo started Celltrion Inc. in 2002 and took it public in 2008.
About Images

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Seo Jung-jin’s rise and global influence.

  • #3   Korea's 50 Richest (2026)
  • #346   Billionaires (2026)

Wealth Growth

Net Worth Growth Over Time

Tracking Seo Jung-jin’s net worth journey over the years, highlighting key growth phases and financial milestones.

Current Net Worth: $7.9B (May 4, 2026)